Pancreatic cancer is a lethal disease that is commonly diagnosed at a late stage. Screening asymptomatic patients is necessary for early detection, but this is not currently recommended in the general population. As demonstrated in the current study, an important number of patients at increased risk can be diagnosed using either MRI/magnetic resonance cholangiopancreatography or endoscopic ultrasound. Further collaborative efforts are needed to define the ideal population for testing and refine the current approach to pancreatic cancer surveillance.
1Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Correspondence: Phil A. Hart, MD. E-mail: firstname.lastname@example.org.
Received January 28, 2019
Accepted February 11, 2019